SpringWorks Therapeutics - 54 Year Dividend History | SWTX
Historical dividend payout and yield for SpringWorks Therapeutics (SWTX) since 1971. The current TTM dividend payout for SpringWorks Therapeutics (SWTX) as of February 21, 2025 is $0.00. The current dividend yield for SpringWorks Therapeutics as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$4.458B |
$0.192B |
|
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
